Vaccinium corymbosum
| Criteria | Criteria Required? |
|---|---|
| Import Permit | Yes |
| Phytosanitary Certificate | Yes |
| Additional Declaration/Endorsement | Yes |
| Protocol Market | No |
All nursery stock must be sourced from an accredited nursery.
The in vitro seedlings must come from mother plants grown at the production site of an accredited nursery.
Any wooden packaging must bear the ISPM 15 logo.
Note: Exporter must add the below point in the product description field of the RFP.
“The plants of this shipment are produced at the production site of (name of the nursery and its address) in Australia".
To enable the additional product description field on the RFP the exporter must submit a request to the EXDOC Plant Programs via email (EXDOCPlantPrograms@aff.gov.au).
Option1 (EXDOC Endorsement 7974)
1 The tissue cultures are produced in a nurseryofficially approved by the Australian NPPO and sent directly to Morocco.
2) Pierce's disease (Xylella fastidiosa), Blueberry shoestring virus (BSSV), Tomato ring spot virus (ToRSV) and Blueberry leaf mottle virus (Nepovirus myrtillin) are not known to occur in Australia,
3) The in vitro seedlings in this consignment have been tested and found freeof Tobacco ring spot virus (TRSV),
4) The in vitro seedlings in this consignment have been inspected andfound to be free of Agrobacterium tumefaciens.
5) During the packaging and consignment procedures, the in vitro seedlings inthis consignment are protected from all phytosanitary contamination.
6) The in vitro seedlings in this consignment come from mother plants grown atthe production site of the approved nursery.
Import permit dated 23 January 2026
Import permit dated 03 December 2024
15/01/2026 - General requirements updated to reflect nursery accreditation requirement.
13/12/2024 - Created case based on NPPO requirements.